ACROBiosystems recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips via ACRO Certify and its Aneuro brand. Two companies have agreed to work together to accelerate neurological....
The three production linked incentive (PLI) schemes in the pharmaceuticals and medical devices sector have attracted a total investments to the tune of Rs. 21,861 crore till March, 2023, with majority of the investments going into the PLI scheme...
Sudhansh Pant, a senior IAS officer, has been named the new Health Secretary as part of the Centre's top-level bureaucratic reshuffle on Tuesday. Pant, a Rajasthan cadre Indian Administrative Service (IAS) officer from the 1991 batch,...
Hari Bhartia, Founder and Co-Chairman of Jubilant Bhartia Group, explored the opportunities for collaboration between India and the United States in an interview at the CNBC-TV18 USIBC India Ideas Summit. The two countries are investigating....
Zydus Lifesciences Limited (Zydus) has announced that the United States Food and Drug Administration (USFDA) has granted final approval to manufacture and market Varenicline Tablets, 0.5 mg and 1 mg....
Granules India Limited, a vertically integrated, rapidly growing Indian pharmaceutical company, announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for metoprolol succinate extended-release tablets USP, 25 mg, 50 mg, 100..
TR Life Sciences a hospital management consulting firm has noted that because of the booming growth, many Indian hospital entrepreneurs are wanting to spread their wings to other countries. They intend to leverage their strengths in global markets,..
In a $3.5 billion transaction, Novartis will acquire US-based Chinook Therapeutics, a clinical-stage biopharmaceutical business. Upon reaching specific regulatory milestones, Chinook common investors will earn $3.2 billion and $0.3 billion in cash...
A current Active Pharmaceutical Ingredient (API) production plant in Denmark will be expanded as part of Novo Nordisk's announced plans to invest 15.9 billion Danish kroner beginning in 2023 for the company's future portfolio of major chronic...
In addition to being a prospective market with strong growth, Bayer Pharma sees India as a hub for innovation, R&D, and potential partnerships, according to the company's top executives.
, CDSCO.jpg)
